LCM
IDXX icon

Laurion Capital Management’s Idexx Laboratories IDXX Stock Holding History

Laurion Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31,200
Closed -$10.2M – 476
2022
Q3 		$10.2M Buy
+31,200
New +$11.5M 0.06% 187

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Laurion Capital Management's IDXX Position: Q3 2024 in Review

Laurion Capital Management sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 23,263 shares — an estimated $11.3M sold.

Laurion Capital Management first reported a position in IDXX in Q4 2016 and held it in 8 quarters. The position peaked at $12.6M in Q1 2024. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Laurion Capital Management reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • Laurion Capital Management sold 23,263 Idexx Laboratories shares in Q3 2024, an estimated $11.3M.
  • Laurion Capital Management first reported a position in Idexx Laboratories in Q4 2016 and held it in 8 quarters.
  • Laurion Capital Management's Idexx Laboratories position peaked at $12.6M in Q1 2024.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.